- Home
- ANNX vs EXTO Comparison
ANNX vs EXTO Comparison
Compare ANNX & EXTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- EXTO
- Stock Information
- Founded
- ANNX 2011
- EXTO 1949
- Country
- ANNX United States
- EXTO Colombia
- Employees
- ANNX N/A
- EXTO N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- EXTO
- Sector
- ANNX Health Care
- EXTO
- Exchange
- ANNX Nasdaq
- EXTO Nasdaq
- Market Cap
- ANNX 668.8M
- EXTO 689.5M
- IPO Year
- ANNX 2020
- EXTO N/A
- Fundamental
- Price
- ANNX $5.14
- EXTO $3.80
- Analyst Decision
- ANNX Strong Buy
- EXTO
- Analyst Count
- ANNX 7
- EXTO 0
- Target Price
- ANNX $15.80
- EXTO N/A
- AVG Volume (30 Days)
- ANNX 1.4M
- EXTO 38.8K
- Earning Date
- ANNX 11-14-2024
- EXTO 01-01-0001
- Dividend Yield
- ANNX N/A
- EXTO 1.60%
- EPS Growth
- ANNX N/A
- EXTO 172.08
- EPS
- ANNX N/A
- EXTO 0.01
- Revenue
- ANNX N/A
- EXTO $5,038,935,945.00
- Revenue This Year
- ANNX N/A
- EXTO $0.80
- Revenue Next Year
- ANNX N/A
- EXTO $3.07
- P/E Ratio
- ANNX N/A
- EXTO $95.90
- Revenue Growth
- ANNX N/A
- EXTO N/A
- 52 Week Low
- ANNX $2.27
- EXTO $3.71
- 52 Week High
- ANNX $8.40
- EXTO $7.30
- Technical
- Relative Strength Index (RSI)
- ANNX 20.42
- EXTO 33.86
- Support Level
- ANNX $5.05
- EXTO $3.75
- Resistance Level
- ANNX $7.63
- EXTO $3.97
- Average True Range (ATR)
- ANNX 0.37
- EXTO 0.23
- MACD
- ANNX -0.23
- EXTO -0.03
- Stochastic Oscillator
- ANNX 3.68
- EXTO 10.71
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About EXTO Almacenes Exito S.A. each representing eight (8)
Almacenes Exito SA is a Colombian retailer that operates in its homeland and overseas. The company operates under three reportable segments Grupo Exito, Carulla, Low cost, and others in Colombia; Libertad in Argentina; and Disco, Devoto, and Geant chains in Uruguay. Exito has an omnichannel, multiformat, and multibrand model. Its store offerings include groceries and food, clothing, home appliances, oil-based liquid fuels, biofuels, personal care products, and home entertainment electronic and digital products.